AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doménech-Sánchez, A.
Right arrow Articles by Benedí, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doménech-Sánchez, A.
Right arrow Articles by Benedí, V. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3332-3335, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3332-3335.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial Resistance

Antonio Doménech-Sánchez,1,2 Luis Martínez-Martínez,3,4* Santiago Hernández-Allés,1,2 María del Carmen Conejo,3 Álvaro Pascual,3,4 Juan M. Tomás,5 Sebastián Albertí,1,2,6 and Vicente Javier Benedí1,2

Laboratory of Microbiology, Department of Biology, University of the Balearic Island,1 IMEDEA (CSIC-UIB),2 Research Unit, University Hospital Son Dureta, Palma de Mallorca,6 Department of Microbiology, School of Medicine, University of Seville,3 University Hospital V. Macarena, Seville,4 Department of Microbiology, University of Barcelona, Barcelona, Spain5

Received 25 February 2003/ Returned for modification 21 April 2003/ Accepted 12 July 2003

OmpK35 from Klebsiella pneumoniae is the homologue of Escherichia coli OmpF porin. Expression of OmpK35 in K. pneumoniae strain CSUB10R (lacking both OmpK35 and OmpK36) decreased the MICs of cephalosporins and meropenem >=128-fold and decreased the MICs of imipenem, ciprofloxacin, and chloramphenicol >=8-fold. MIC reductions by OmpK35 were 4 times (cefepime), 8 times (cefotetan, cefotaxime, and cefpirome), or 128 times (ceftazidime) higher than those caused by OmpK36, but the MICs were similar or 1 dilution lower for other evaluated agents.

* Corresponding author. Mailing address: Department of Microbiology, School of Medicine, University of Seville, Apdo. 914, 41080 Seville, Spain. Phone: 34-955008287. Fax: 34-954377413. E-mail: lmartin{at}us.es.

Antimicrobial Agents and Chemotherapy, October 2003, p. 3332-3335, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3332-3335.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.